Chronic Care


There is between 50% – 80% likelihood that a cardiovascular patient has poor sleep quality or untreated sleep disorder breathing. Improved sleep quality and successfully treated sleep apnea reduce the risk of further progression of cardiovascular diseases.

Sleep testing and treatment of sleep disorders should be included as standard of care in cardiology practices, as good sleep quality has been associated with improved blood pressure control, mitigation of arrhythmias often leading to more successful pharmaceutical interventions and increased quality of life.

Good Sleep Quality is crucial to blood glucose and cortisol management, which can lead to increased risk of obesity and diabetes if left untreated. Most patients who have developed obesity and/or diabetes type 2 have sleep apnea, which studies have shown to have been commonly treated as Insomnia in the absence of objective sleep testing.

The likelihood of poor sleep quality and untreated sleep apnea in these patients is high while it is fundamentally important to manage these conditions in these patients, as the absence of successful intervention will make the management of cardiometabolic diseases more difficult leading to increased risk of the onset of further adverse conditions such as chronic kidney disease.

Chronic sleep problems and poor sleep quality affect up to 80% of people who suffer from poor mental health, such as stress, anxiety, depression, PTSD, bipolar disease and ADHD compared to less than 20% in the general population.

Many pharmaceutical interventions aimed at improving mental health, cause adverse effects on sleep quality causing sleep fragmentation that adversely affects the disease management.

It is vitally important for any mental health management to include management of sleep quality and intervention for sleep disorders, as otherwise it may become next to impossible to optimize the mental health management.